Your browser doesn't support javascript.
loading
Inactivation of SARS CoV-2 on porous and nonporous surfaces by compact portable plasma reactor.
Choudhury, Bhaswati; Lednicky, John A; Loeb, Julia C; Portugal, Sherlie; Roy, Subrata.
Afiliação
  • Choudhury B; SurfPlasma, Inc., Gainesville, FL, United States.
  • Lednicky JA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States.
  • Loeb JC; Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States.
  • Portugal S; Department of Environmental and Global Health, University of Florida, Gainesville, FL, United States.
  • Roy S; Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States.
Front Bioeng Biotechnol ; 12: 1325336, 2024.
Article em En | MEDLINE | ID: mdl-38486867
ABSTRACT
We report the inactivation of SARS CoV-2 and its surrogate-Human coronavirus OC43 (HCoV-OC43), on representative porous (KN95 mask material) and nonporous materials (aluminum and polycarbonate) using a Compact Portable Plasma Reactor (CPPR). The CPPR is a compact (48 cm3), lightweight, portable and scalable device that forms Dielectric Barrier Discharge which generates ozone using surrounding atmosphere as input gas, eliminating the need of source gas tanks. Iterative CPPR exposure time experiments were performed on inoculated material samples in 3 operating volumes. Minimum CPPR exposure times of 5-15 min resulted in 4-5 log reduction of SARS CoV-2 and its surrogate on representative material samples. Ozone concentration and CPPR energy requirements for virus inactivation are documented. Difference in disinfection requirements in porous and non-porous material samples is discussed along with initial scaling studies using the CPPR in 3 operating volumes. The results of this feasibility study, along with existing literature on ozone and CPPR decontamination, show the potential of the CPPR as a powerful technology to reduce fomite transmission of enveloped respiratory virus-induced infectious diseases such as COVID-19. The CPPR can overcome limitations of high temperatures, long exposure times, bulky equipment, and toxic residuals related to conventional decontamination technologies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos